Testing effectiveness (Phase 2)UnknownNCT04346368
What this trial is testing
Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)
Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Guangzhou Institute of Respiratory Disease 20